IntroductIon
Inhalational anesthetics agents have been used for surgical anesthesia and analgesia. In 1954, Charles Suckling presented the first modern halogenated inhalational anesthetics agent, halothane. [1] Then, other halogenated inhalational anesthetic agents, including enflurane and isoflurane, were performed. [2] Sevoflurane and desflurane are the most recent contributors of halogenated inhalational agents. [1, 2] pharmacokInetIcs By inhalation of anesthetics agents, they reach the alveoli and quickly pass through the alveolar membrane. Then, the bloodstream transfers the agents to all perfused organs. For an anesthetic agent, the blood gas partition coefficient and the relative solubility determine the rate of increase in alveolar concentration (end-tidal) toward inspired concentrations. [1, 2] Poorly soluble inhalational agents that have low blood-gas partition coefficients (e.g., sevoflurane) have more anesthetical effectiveness compared to high-soluble anesthetic agents with high blood-gas partition coefficients (e.g., halothane). [1, 2] The chemical structures of sevoflurane and halothane are represented in Figure 1a and b, respectively. Other elements that affect the level at which equilibrium is setup are as follow: (a) hyperventilation that reduce the required time for equilibrium setup, (b) high cardiac output that heighten the required time, and (c) high rates of uptake by various tissues that can heighten the time for setup the equilibrium between gas and blood. [1] For different agents including therapeutic or toxic agents, several factors can determine the rate of the uptake to a particular tissue. [1] [2] [3] [4] [5] [6] [7] The factors include partial pressure difference between artery and tissues, the tissue-blood solubility coefficient, volume of tissues, and blood perfusion. In brain, heart, and kidney tissues that have high blood flow, concentrations of the agents equilibrate with their blood concentrations within hours. Some tissues such as fat have a low blood flow. Therefore, in such tissues, concentrations of the agents require several days to equilibrated with the blood concentrations. [1] [2] [3] [4] [5] [6] [7] Inhalational anesthetics agents are essentially eradicated through the respiratory system. Nevertheless, all inhalational anesthetics Inhalational Anesthetics Agents: The Pharmacokinetic, Pharmacodynamics, and their Effects on Human Body may be metabolized in different rates. [2] About 15%-20%, 5%, and 0.2% of inhaled halothane, [8] sevoflurane, [9] and isoflurane [10] are metabolized, respectively. [11] Modern inhalational anesthetic agents are mainly metabolized by cytochrome P450 in the liver and produce several metabolites, such as inorganic fluoride, that are eliminated through the urinary system. [2, 11] pharmacodynamIcs Mean alveolar concentration (MAC) has been utilized as routine criteria to determine the efficiency of inhalational anesthetics agents. [12] In definition, MAC is a concentration of an inhalational anesthetics agent that prevents muscular movements in reaction to the surgical stimulation in 50% of individuals. Values of MAC change for various agents and are dependent to the patients' ages. For example, in neonates, MAC of sevoflurane is almost 3.3%, and in adults aged 40-50 years, it is near 2%. [12, 13] 
Impact in central nervous system
The functional mechanisms of inhalational anesthetics agents are known in some aspects. [13, 14] Functional mechanisms of the agents were affected by the Meyer-Overton rule for more than a century. Meyer-Overton rule indicates a relationship between the lipid solubility of inhalational anesthetics agents and their anesthetic effectiveness. [15, 16] Inhalational anesthetic modifies the electrical action of the central nervous system that can be assessed using electroencephalogram. Enflurane can enhance epileptic waves, while desflurane and isoflurane do not induce epileptic activity. [17] Information about sevoflurane in this aspect is arguable. Using isoflurane and sevoflurane, one can suppress convulsions in patients with intractable epilepsy. [18] Inhalational anesthetics partly influence on the cerebrovascular CO 2 sensitivity. In clinical concentrations, desflurane and isoflurane lead to decrease in cerebral blood flow but preserve responsiveness of cerebral circulation to CO 2 . [19] 
Cardiovascular impacts
Inhalational anesthetics decrease cardiac output and mean arterial pressure (MAP) in a dose-relative mode. Sevoflurane, isoflurane, and desflurane decrease the MAP through decreasing the systemic vascular resistance. [20, 21] In 1985, it was [22] suggested that enflurane may increase postischemic myocardial recovery in isolated rat hearts. [22] Afterward, it was shown that exhibition to anesthetics agents simulate the cardioprotective influences of repetitive ischemia. [23] This event has been named pharmacological preconditioning. [23] To protect myocardium and minimize ischemia-reperfusion myocardium injury, preconditioning and postconditioning treatments are performed before and after ischemic events, respectively. [23] In several researches, the possible advantages of myocardial protection by anesthetics agents, the mechanisms of protection and preconditioning and postconditioning through inhalational anesthetics have been widely investigated in vivo and in vitro. The agents protect myocardium through opening of K ATP channels [24] [25] [26] and increasing of reactive oxygen species (ROS) in mitochondria. [26, 27] Besides, they can stimulate or translocate the tyrosine kinase, protein kinase C, and p38 mitogen-activated protein kinase. [26] Such mechanisms can reduce content of cytosolic and mitochondrial calcium. [28] In two meta-analyses, cardioprotective effects of inhalational anesthetics were discussed. The results showed that morbidity and mortality in patients experiencing cardiac surgery were decreased. [29, 30] In a recent study, to promote late pharmacological conditioning, inhalational sevoflurane was used. Results showed that even a low dose, late and short applied of the agent can induce cardiac protection. [31] 
Respiratory effects
Inhalational anesthetic agents reduce tidal volume and depress spontaneous breathing. [32] They increase the threshold of CO 2 to activate respiratory centers and decrease in ventilation that leads to CO 2 accumulation. [33, 34] Sevoflurane can decrease airway resistance. [35] A number of case reports have revealed prosperous healing of status asthmaticus with sevoflurane. [36] [37] [38] 
Relation between oxidative stress in one-lung ventilation and inhalational anesthesia
In thoracic surgery, one-lung ventilation (OLV) is commonly carried out to prepare expanded surgical space. At the time of the OLV, in the nonventilated lung, a hypoxic pulmonary vasoconstriction occurs and the oxygenation and perfusion diminishes, while the blood flow of the other lobe heightens. Consequently, the nonventilated site undergoes a tissue ischemia. After resuming two-lung ventilation (2 LV), the production of ROS increase quickly and meaningfully as a result of the reperfusion of the blood and reentry of oxygen to the ischemic tissue. [39] Increasing of ROS leads to peroxidation of unsaturated lipids in plasma lipoproteins as well as cell membranes. [40] This phenomenon is named ischemia-reperfusion injury (IRI) that may generate a number of cardiac complications. [41] Ability of human cells to act against oxidative stress depends on the their total antioxidant status (TAS). After the treatment of pneumothorax and initiating the 2 LV, hydrostatic pressure increases and leads to increase in alveolocapillary membrane permeability. [42, 43] It can lead to a lung edema. It was revealed that in acute pulmonary damages, TAS is reduced by pulmonary edema fluid. [44] Serious oxidative damages that is appeared after 2 LV, can be remarkable in subjects without suitable TAS. [39] Aim to prevent IRI, several studies have been conducted. [45] [46] [47] [48] [49] [50] [51] [52] Fatty acid peroxidation and reperfusion damage can be prevented by using antioxidants. For example, propofol, an analogous to phenolic-free radical scavengers [ Figure 1c] , can be employed. [45] [46] [47] [48] [49] Besides, the halogenated inhalation agents such as sevoflurane have been showed to reduce the rate of IRI. [50] [51] [52] When reperfusion of ischemic tissue, levels of ischemia-modified albumin (IMA) and malondialdehyde (MDA) heighten in bloodstream. MDA is a toxic compound that is produced through lipid peroxidation. IMA and MDA have been utilized as markers in studies on IRI. [40] [41] [42] [43] [44] [45] [46] [47] In a study, patients subjected to the thoracic surgery performing the OLV, were surveyed, and the influences of sevoflurane and propofol on IRI were compared. Some important criteria including MDA, IMA, blood-gas levels, and hemodynamics were assessed. Results showed that sevoflurane may protect against IRI induced after OLV in the thoracic surgery. [53] Recovery after using sevoflurane versus halothane Sevoflurane has been considered a valuable candidate for stimulation of anesthesia because of some useful properties as follow: the low-solubility in blood, nonirritant for the respiratory tract, fast-inducer of the anesthesia, and inducing the patients' hemodynamic in a constant route. Fast recovery is worthwhile to confirm early efficient coughing and reduce the percentage of postoperative airway problems. In a comparative research, patients who had received either halothane or sevoflurane to keep anesthesia during operation, were compared for the features of their postoperative recovery. Results showed that sevoflurane induced less recovery time and minimum time to obtain discharge criteria. [54] Wake-up times after using sevoflurane or propofol in cardiac surgery
In Intensive Care Unit (ICU) patients, to induce tolerance to the tracheal tubes and mechanical ventilation, sedative infusions have been used. However, wake-up times after using these agents is unpredictable. Moreover, they may not be suitable to use for prolonged mechanical ventilation. Benzodiazepines and propofol may be partly responsible for the promoting of delirium and delusional memories. Compared to midazolam, the inhaled isoflurane induces delusional memories in a lower rate while using for sedation in ICU. In a randomized control trial, the cardiac effects of performing sedation by sevoflurane were compared with propofol following coronary artery bypass surgery. Compared to propofol, sedation by sevoflurane resulted in lower wake-up times and faster cooperation after cardiac surgery. No changes were observed in the stay time in the ICU, damaged memories, and recovery events in short-range sedation. [55] Xenon is capable to reduce memories of traumatic events Xenon (Xe) is a noble gas used for inhalational anesthesia and diagnostic imaging. The gas has some properties to use as a perfect anesthetics agent; however, the practical complication of the Xe apparatus and the high price of the gas have limited its extensive using. As an anesthetic, Xe has some advantages including fast induction, low solubility in blood and tissues, and inducing stable hemodynamics in patients with damaged cardiac activity. [56] Xe prevents glutamate receptors associated with memory and learning. It can also influence synaptic flexibility in the brain areas including amygdala and hippocampus. These areas involve in fear conditioning models of posttraumatic stress disorder (PTSD). The glutamate receptors are effective in fear memory reconsolidation, a condition in which recalled memories become sensitive to alternation. In a study, Xe (25%, 1h) was administered in rats after fear memory reactivation and its potency to influence fear memory reconsolidation and next expression of fear-like behavior assessed. Results showed that Xe could considerably inhibit memory reconsolidation in a time-dependent mode. It was suggested that Xe could be employed as a novel factor to study representation of reconsolidation and other memory procedures. It may be utilized to treat patients with diseases associated with emotional and fear memories (e.g., PTSD). [57] Gas drugs in Intensive Care Unit Overall, gas drugs have extensive usage in ICU. For example, a combination of oxygen and helium may be utilized in patients with obstructive airway disorders, endotracheal tubes, acute lung damage, diphtheria, respiratory distress syndrome, asthma, bronchiolitis, and chronic obstructive pulmonary disease. [58] conclusIon It can be concluded that inhalational anesthetic agents can be used in anesthesia and ICU. The agents have beneficial effects on a wide range of patients including the patients with status epileptics, exacerbations of obstructive lung disease, or ischemic heart disease. Yet, utilizing the inhalational anesthetics in an ICU is impeded if usual anesthetic circuits should be employed.
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